Your Life, Your Health: CVS Health's response to Dr. Holly, Part 2

James Holly, M.D.

CVS Health Caremark continued the promotion of its plans regarding opioids in the September 21, edition of Health Affairs in a blog co-authored by Caremark’s Chief Medical Officer.

Caremark’s CMO: “In the last two decades, prescribing rates for opioids have increased nearly three-fold, from 76 million prescriptions in 1991 to approximately 207 million prescriptions in 2013. This remarkable volume of opioid prescribing is unique to the United States, where 2015 prescribing amounts were nearly four times those in Europe. Sadly, this much more frequent prescribing of addictive medications is connected to an epidemic of deaths related to abuse of opiates and other drugs of abuse. Drug overdose deaths are now considered a national emergency, topping 59,000 in 2016. The abuse of opioids can be seen as the leading public health emergency in the United States faces today.”

While I will not quibble with this statement, I would argue that access to care, affordability of care, alcohol addiction, murder rates among minorities, abuse and/or neglect of the elderly, disparities of care and child abuse and hunger are also leading public health emergencies in this country. If the authors said that the abuse of opioids is “a” leading public health emergency in the U.S.,” it would solve this rhetorical deficiency.

The startling increase in the use of opioids has many causes. Two decades ago, health providers perceived that pain was undertreated, and in 1998 the Joint Commission formally recognized pain as the fifth vital sign. At the same time, drug companies developed and promoted a new generation of synthetic opioids, and added extended release as well as abuse deterrence formulations. Doctors prescribed, and patients consumed, these drugs in ever increasing quantities. At the same time, illicit forms of opioids became more widely available and abused. Now, with the harrowing increase in mortality attributed to opioid abuse, it is time to look for new solutions.

As the adverse consequences resulting from opioid misuse became apparent, employers sought the help of pharmacy benefit managers, which responded by developing prospective (i.e., pre-dispensing) and retrospective utilization review programs to detect and intervene in unsafe prescribing of these addictive medications. Patients and prescribers who were engaged in unsafe behavior were identified and educated. Other interventions, in the form of member-specific drug limits, dispensing restricted to a single pharmacy, and prior authorization to ensure use for an appropriate diagnosis, were implemented – all programs shown to reduce opioid abuse. These programs had positive effects, but the magnitude of the opioid epidemic continued to increase.

Seems contradictory that these measures helped but evidence is that “the magnitude of the opioid epidemic continued to increase.” None of these programs or processes interfered with the appropriate prescribing of medications but then CVS Health was not as brazen then as it has become since.

Caremark’s CMO: “With widespread recognition that more aggressive control was called for, the Centers for Disease Control and Prevention (CDC) assumed the lead, announcing a Guideline for Prescribing Opioids for Chronic Pain in 2016. The CDC Guideline was based on three principles: opioids should be used only when necessary; only at the lowest dose and for the briefest duration needed; and when used, caution should be exercised and patients monitored closely. The guideline made specific recommendations such as implementing step therapy requiring the use of immediate release formulations before extended release drugs when initiating treatment for chronic pain, avoiding doses greater than 90 Morphine Milligram Equivalents per day, and limiting prescriptions for acute pain to seven days or less. All of these recommendations can be integrated in standard utilization management.”

It is no oversight that the CDC calls their proposal “guidelines,” not “protocols.” A “guideline” is an evidenced based recommendation, while a “protocol” is a rigid required step-by-step process analysis which must be followed.

What CVS Health calls “standard utilization management” most physicians would call “practicing medicine.” My opinion is that the CDC guideline should be implemented at the practice or provider level rather than at the PBM level. For physicians to monitor physicians and for physician committees to establish “step programs” would be appropriate. For PBMs to disguise their practice of medicine in UM vocabulary is not.

CVS Health is proposing the imposing of the CDC Guidelines in a coercive fashion by the PBM. This is consistent with the philosophy of many progressives and progressive organizations. It is not what the CDC Guideline intended, I think. If the CDC had proposed protocols, legislative or legal coercion may have been appropriate, but the CDC proposed “guidelines,” which are not compulsory.

There is no correlation between the prescribing of an excessive dosage of a medication where an objective, evidenced-based standard exists in the medical literature and the refusal to fill a legal prescription by a legal provider. For instance, if a provider prescribes 160 mgs of Atorvastatin, it could legitimately be rejected as it is objectively a toxic dose.

That is not what CVS Health is proposing for opioids. CVS Health is declaring that in order to control the abuse of these medications, an obviously ineffective way will be employed, which supposedly will made successful simply by making it more difficult to obtain the opioids. That is UM gone amuck and it not a strategy which is likely to success. As evidence one simply has to see the extremes to which people are willing to go to obtain illegal drugs, or to illegally obtain legal drugs.

The bottom line for me in this entire discussion as a primary healthcare provider is that I want to continue to work every day, as I have for the past 44 years, to help people make the right health care decisions, while being fully aware they have the right to make bad decisions. Ultimately, I have the responsibility not to facilitate, or to participate in their bad decisions.

Confronted with CVS Health’s proposal, many, if not most, people who are addicted to prescription drugs will make the same decision that one of my patients made years ago. When I saw her she was enormously overweight, at 5 feet tall, she weighed over 450 pounds. After a careful dietary history, I was convinced that she consuming about 1,700 calories a day. I asked her, “Do you drink cokes?” She answered, “No,” to that and to tea. When I asked about coffee, she admitted that she drank over 40 cups of coffee a day. Before you express incredulity, I once had a patient in residency that drank five cases of beer a day.

When I asked what she put in her coffee, she said that she used two teaspoons of sugar and one tablespoon of fresh cow cream. I talked to her about changing her habits and offered help and encouragement. Pleased that I had practice good, patient-centered care, I was not surprised at her decision.

She changed doctors.

Compulsive and addictive behavior is compulsive and addictive. All the PBMs utilization management will not change that.

shadow